Search - tctmd.com

Displaying 261 - 273 of 273

Sort: Relevancy | Date

News Daily News

Time for Niacin to Be ‘Relegated to Medical History’ as HPS2-THRIVE Analysis Confirms Drug’s Failings

Michael O'Riordan

July 12, 2016

News Daily News

Aspirin as Standalone Stroke Protection Still Overused for Patients With A-fib

Todd Neale

June 27, 2016

News Daily News

利拉鲁肽超越 FDA 安全预期，可降低心血管疾病的死亡率：LEADER

Michael O'Riordan

June 14, 2016

News Daily News

Broader, Primary Prevention Role for High-Sensitivity Troponin Tests Suggested by ARIC Analysis

Shelley Wood

June 10, 2016

News Daily News

Trial Affirms Aspirin Is Safe to Continue Before Coronary Artery Surgery

Todd Neale

February 25, 2016

News Daily News

Triple Therapy, Especially With Prasugrel, Increases Bleeding Risk in Acute MI

Yael L. Maxwell

December 22, 2015

News Daily News

Majority of US Patients Still Discharged on High-Dose Aspirin After Acute MI

Todd Neale

August 20, 2014

News Daily News

Failure to Give Pre-PCI Aspirin Not Infrequent Cause of Complications

Caitlin E. Cox

October 04, 2013

News Daily News

Apixaban Lowers Hospitalization Rate vs. Aspirin in A-fib Patients

Jason Kahn

August 05, 2013

News Daily News

Studies Suggest Less Stringent Dual Antiplatelet Use After DES

September 20, 2012

News Daily News

Pantoprazole Not Necessarily a Safer PPI Choice for Patients on Dual Antiplatelet Therapy

L.A. McKeown

August 01, 2012

News Daily News

Prior Medication Adherence Predicts Post-PCI Clopidogrel Compliance

July 20, 2011

News Daily News

Cilostazol Reduces Repeat Revascularizations for Long Lesions

March 06, 2011

Advertisement

Time for Niacin to Be ‘Relegated to Medical History’ as HPS2-THRIVE Analysis Confirms Drug’s Failings

Aspirin as Standalone Stroke Protection Still Overused for Patients With A-fib

利拉鲁肽超越 FDA 安全预期，可降低心血管疾病的死亡率：LEADER

Broader, Primary Prevention Role for High-Sensitivity Troponin Tests Suggested by ARIC Analysis

Trial Affirms Aspirin Is Safe to Continue Before Coronary Artery Surgery

Triple Therapy, Especially With Prasugrel, Increases Bleeding Risk in Acute MI

Majority of US Patients Still Discharged on High-Dose Aspirin After Acute MI

Failure to Give Pre-PCI Aspirin Not Infrequent Cause of Complications

Apixaban Lowers Hospitalization Rate vs. Aspirin in A-fib Patients

Studies Suggest Less Stringent Dual Antiplatelet Use After DES

Pantoprazole Not Necessarily a Safer PPI Choice for Patients on Dual Antiplatelet Therapy

Prior Medication Adherence Predicts Post-PCI Clopidogrel Compliance

Cilostazol Reduces Repeat Revascularizations for Long Lesions

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content